Advertisement

Picture Berlin Partner BIO 2024 International Convention San Diego 650x100px
Organisation › Details

Redwood Pharma AB

The firm is a pharmaceutical company focused on development of new ophthalmic therapies where there are clear and unmet clinical needs. Redwood Pharma’s lead product in development is a new eye drop designed to treat an underlying cause of chronic Dry Eye Disease in post-menopausal women. Through the IntelliGel® drug delivery platform, a technology developed for controlled release, the company creates exciting opportunities to improve existing therapies and also to develop new ones. *

 

Period Start 2016-02-23 existent
Products Industry RP101 (Redwood Pharma)
  Industry 2 IntelliGel® drug delivery system
Person Person Vidaeus, Martin (Redwood Pharma AB 201602 CEO)
     
Region Region Stockholm
  Country Sweden
  Street 100E Ringvägen
9th Floor
  City 11860 Stockholm
  Tel +46-8-559-34737
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for »About Section«: 
     
   
Record changed: 2024-02-12

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture Berlin Partner BIO 2024 International Convention San Diego 650x300px




» top